AMERICAN CENTURY COMPANIES INC

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 748054 KANSAS CITY, MO

Position in DNA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$974,717

+$439,041 QoQ

Shares Held

98,357

+12.6% QoQ

Ownership

0.146%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#43

of 183 holders

Holding Since

Jun 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AMERICAN CENTURY COMPANIES INC holds $3,568,637,643 across 178 Biotechnology names. DNA ranks #87 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,853,956	$558,096,374
2	ASND	Ascendis Pharma A/S	1,400,575	$373,561,364
3	VRTX	Vertex Pharmaceuticals Inc / Ma	580,901	$288,550,953
4	ARGX	Argenx SE	173,193	$160,683,269
5	IONS	Ionis Pharmaceuticals Inc	1,947,076	$154,383,656
6	EXEL	Exelixis, Inc.	1,791,664	$97,484,438
7	HRMY	Harmony Biosciences Holdings, Inc.	2,539,512	$92,463,631
8	GPCR	Structure Therapeutics Inc.	1,682,179	$90,282,546

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$974,717	98,357	+12.6%	Shares	Defined	2026-08-12
2026-03-31	$535,676	87,386	-1.0%	Shares	Defined	2026-05-15
2025-12-31	$733,731	88,295	+10.2%	Shares	Defined	2026-02-13
2025-09-30	$1,168,412	80,138	+38.5%	Shares	Defined	2025-11-12
2025-06-30	$650,981	57,865	+73.9%	Shares	Defined	2025-08-12
2025-03-31	$189,690	33,279	-79.6%	Shares	Defined	2025-05-13
2023-09-30	$295,569	163,298	+56.8%	Shares	Defined	2023-11-13
2023-06-30	$193,681	104,130	-0.2%	Shares	Defined	2023-08-14
2023-03-31	$138,820	104,376	0.0%	Shares	Defined	2023-05-11
2022-12-31	$176,395	104,376	+91.5%	Shares	Defined	2023-02-13
2022-09-30	$170,096	54,518	+400.9%	Shares	Defined	2022-11-14
2022-06-30	$25,903	10,884	—	Shares	Defined	2022-08-12
No filing history on record for this holder in this stock.